DYNAMICS OF CHANGES OF THE HEMATOKRIT LEVEL IN NEWBORNS IN CRITICAL CONDITIONS IN RESPONSE TO SELENASE’S INTRODUCTION

Abstract

Purpose: To improve the results of treatment of newborns with respiratory distress syndrome (RDS) and perinatal CNS (central nervous system PP), being in critical conditions, by selenium use.Materials and Methods: blind, controlled, randomized clinical trial application of selenase in newborn babies with RDS and PP CNS with artificial ventilation (AV) was carries out. 76 newborn children being in a critical condition were surveyed. Randomization was carried out by a computer program of a random number generator. In Group I (n = 36), selenase was entered in doses of 10 mg / kg / day intravenously slowly for 10 days, II group (n = 40) - control group.Results: during the test it was found and statistically proved that the group of children receiving selenase, there is an increase by 1,01 times (р < 0,05) level of hematocrit.Summary: level increase of hematocrit, promoted decrease (by 1,1 times) frequencies of development of anemias at children of the I group and by that, reduced the duration of carried-out IVL and hospitalization duration.

Keywords

• hematocrit
• selenium
• respiratory distress syndrome at newborn babies